Coronavirus - The New Generation Influenza Psychiovirus

Review of Therapeutic Candidates for the New Coronavirus disease (COVID19)

Background: COVID-19 infectious disease caused by the sever acute respiratory syndrome coronavirus 2 (SARS-CoV-2) occurred in late November 2019 in Wuhan, China and has become a worldwide health crisis. The World Health Organization has identified COVID-19 as a public health priority of international concern. This is because the epidemic has become a pandemic and there is no effective antiviral...

New therapeutic strategies in treating the new Coronavirus 2019: review article

The highly contagious new coronavirus virus, SARS-CoV-2, was first appeared in Wuhan, China in late 2019. The virus has spread to 216 countries, including Iran, until 7 September 2020. So far, the number of people infected by the new corona virus and died from the disease is 27032617 and 881464 worldwide, respectively. Therefore, it is necessary to introduce the available treatments for this vi...

the h۵n۸ virus: a new emerging influenza

New mutations causing the 2019 novel Coronavirus (2019-nCoV) epidemic: letter to the editor

No

New mutations causing the 2019 novel Coronavirus (2019-nCoV) epidemic: letter to the editor

[Full text in Persian]